Stock MANGALAM MANGALAM DRUGS & ORGANICS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Mangalam Drugs & Organics Limited NSE India S.E.

Equities

MANGALAM

INE584F01014

Pharmaceuticals

Market Closed - NSE India S.E.
Other stock markets
 08:01:55 18/05/2024 BST 		5-day change 1st Jan Change
101.3 INR +1.50% Intraday chart for Mangalam Drugs & Organics Limited +5.58% +3.21%
02-13 Mangalam Drugs & Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
2023 Mangalam Drugs & Organics Limited Reports Earnings Results for the Half Year Ended September 30, 2023 CI

Business Summary

Mangalam Drugs and Organics Limited is an India-based manufacturer of active pharmaceutical ingredients (APIs) and intermediates. Under the Company's Fight Malaria Program, it supplies anti-malaria APIs worldwide. Its products include API, intermediates and specialty chemicals. Its API products include acyclovir, amodiaquine, artemether, artesunate, atazanavir sulfate, bisoprolol fumarate, chloroquine phosphate, furosemide and dolutegravir sodium. The Company's intermediates products include 4,6-Dichloro-5-Methoxy Pyrimidine; 4,7- dichloroquinoline; ortho phenoxy methane sulfonanilide; tenofovir alafenamide base, and tenofovir disoproxil base. Its specialty chemicals products include L (+)-menthol; 2,3-dihydrophthalazine-1,4-dione or phthalazine-1,4-dione, and 4-cynoethyl-2-methyl phenol. Its pipeline APIs (under development) include Ganaplacide (IH), Tafenoquine Succinate (IH) and Pretomanid (IH). Its pipeline APIs (developed at research and development) is Bictegravir Na (IH).

Number of employees: 523

Sales per Business

INR in Million2022Weight2023Weight Delta
Bulk Drugs
100.0 %
4,476 100.0 % 3,702 100.0 % -17.29%

Sales per region

INR in Million2022Weight2023Weight Delta
India
100.0 %
4,476 100.0 % 3,702 100.0 % -17.29%

Managers

Managers TitleAgeSince
Govardhan Murlidhar Dhoot CEO
 Chief Executive Officer 70 15/04/96
Ajay A. Samant DFI
 Director of Finance/CFO - -
Jayant Barde CMP
 Compliance Officer 30 07/02/22

Members of the board

Members of the board TitleAgeSince
Govardhan Murlidhar Dhoot CEO
 Chief Executive Officer 70 15/04/96
Praveen Saxena BRD
 Director/Board Member 68 20/03/21
Brijmohan M. Dhoot BRD
 Director/Board Member 72 04/02/15
Rukmesh P. Dhandhania BRD
 Director/Board Member 44 19/11/17
Nidhi S. Mundada BRD
 Director/Board Member 35 27/05/18
Rakesh Kishinchand Milwani BRD
 Director/Board Member - 09/03/22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 15,828,200 7,169,917 ( 45.30 %) 0 45.30 %

Shareholders

NameEquities%Valuation
Shree Kishoriju Trading & Investment Pvt Ltd.
6.940 %
1,098,515 6.940 % 1 M ₹
SHREE RASBIHARI TRADING & INVESTMENT PVT LTD
6.392 %
1,011,663 6.392 % 1 M ₹
Radhika A Dhoot
1.848 %
292,500 1.848 % 357 754 ₹

Company contact information

Mangalam Drugs & Organics Ltd.

Rupam Building 239, P. D'Mello Road

400001, Mumbai

+91 22 6261 6200

http://www.mangalamdrugs.com
address Mangalam Drugs & Organics Limited(MANGALAM)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sector Generic Pharmaceuticals

1st Jan change Capi.
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+21.63% 44.11B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+23.03% 22.71B
SANDOZ GROUP AG Stock Sandoz Group AG
+18.22% 15.15B
CIPLA LIMITED Stock Cipla Limited
+12.66% 13.56B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+60.18% 12.7B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-10.02% 6.84B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+12.92% 5.63B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 532637 Stock
  4. MANGALAM Stock
  5. Company Mangalam Drugs & Organics Limited